说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 供者淋巴细胞输注
1)  Donor lymphocyte infusion
供者淋巴细胞输注
1.
To explore whether the complete donor chimerism could be achieved and graft-versus-host disease could be alleviated by donor lymphocyte infusion which was sensitized by the skin of the recipient, female C57BL/6 mice (H-2~b, B6) as recipients received total body irradiation (TBI) of 5.
本研究目的是探讨经受者皮肤致敏后的异基因供者淋巴细胞输注(DLI)是否能在促进形成完全供者嵌合(CC)的同时减轻移植物抗宿主病(GVHD)。
2.
Objective To explore the effect of donor lymphocyte infusion on H22 hepatoma mice.
目的:观察供者淋巴细胞输注(DLI)对小鼠H2 2肝癌的治疗作用。
3.
ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases.
【目的】研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。
2)  DLI
供者淋巴细胞输注
1.
2 weeks after NST, the donor lymphocytic infusion (DLI) was given , and at totals 5 to 6 times for each patient.
方法 :采用氟达拉宾、白消安、抗人淋巴细胞球蛋白和骁悉的非清髓性预处理 ,异基因造血干细胞移植 ,移植后 2周开始供者淋巴细胞输注 (DLI) ,每例 5~ 6次 ;应用STR PCR及染色体核型分析检测供者嵌合体 ;每半月~ 1个月监测血型。
3)  donor lymphocytes infusion
供者淋巴细胞输注
1.
Objective To investigate the clonal expansion of T cell receptor (TCR) V? subfamily T cells which were considered as GVL effective cells alter donor lymphocytes infusion ( DLI) in patients with relapse chronic myelogenous leukemia (CML) after allogeneic hone marrow transplantation (allo-BMT).
目的 了解供者淋巴细胞输注(DLI)治疗异基因骨髓移植(allo-BMT)后慢性粒细胞白血病(CML)复发患者,产生GVL效应的克隆性TCRVβ亚家族T细胞的情况。
4)  Donor lymphocyte infusion
供体淋巴细胞输注
1.
Tumor growth in mouse allogeneic chimeras and antitumor effects of donor lymphocyte infusion;
异源嵌合体小鼠体内肿瘤生长情况及供体淋巴细胞输注的抗肿瘤反应
5)  lymphocyte transfusion
淋巴细胞输注
6)  halotype lymphocyte infusion
单倍体淋巴细胞输注
1.
In order to observe the curative and side effects in malignant hematologic diseases treated with autologous peripheral blood stem cell transplantation (auto PBSCT) combined with halotype lymphocyte infusion, auto PBSCs were mobilized, harvested and stored at -196℃ from patients in first CR or PR with intensive chemotherapy (Ara C 1.
为观察自体外周血干细胞移植联合单倍体淋巴细胞输注治疗恶性血液病的疗效和不良反应 ,对完全缓解或部分缓解的恶性血液病患者用中剂量阿糖胞苷 (1。
补充资料:输供
1.输送供给。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条